- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$15.99 BnMarket Estimate, 2026
$16.60 BnMarket Forecast, 2034
$22.37 BnCAGR, 2026–2034
3.8%Global Non-Animal Softgel Capsule Market Size, Growth, Trends & Forecast (2026–2034)
The size of the global non-animal softgel capsule market was valued at USD 15.99 billion in 2025, is estimated at USD 16.60 billion in 2026, and is projected to reach USD 22.37 billion by 2034, registering a compound annual growth rate (CAGR) of 3.8% from 2026 to 2034. Driven by a rising preference for vegan, gluten-free, and clean-label dietary options, increasing geriatric demographics, and surging environmental and health awareness, the market continues to experience steady worldwide expansion.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 15.99 Billion
- 2026 Current Valuation: USD 16.60 Billion
- 2034 Forecast Valuation: USD 22.37 Billion
- Compound Annual Growth Rate (CAGR): 3.8% (2026–2034)
- Dominant Application Segment: Health Supplements & Pharmaceuticals (experiencing high demand due to clean-label health trends and ease-of-swallowing benefits)
- Dominant Region: Asia-Pacific (APAC) (holding a massive share driven by a growing aging population, high export demands in countries like Malaysia and Indonesia)
- Fastest-Growing / Promising Region: Europe (notable market potential propelled by rapidly rising health awareness and plant-based supplement preferences)
Core Market Drivers
- Clean-Label & Dietary Shifts: Growing consumer preference for gluten-free, halal/kosher-certified, tasteless, and odorless non-animal capsule variants over traditional animal gelatin.
- Aging Population & Environmental Awareness: Increasing geriatric demographics seeking comfortable oral dosage forms alongside an expanding market for eco-friendly products.
Primary Market Restraints & Challenges
- High Production Costs: Non-animal softgel variants are inherently more expensive to manufacture than existing animal gelatin versions, restricting rapid market penetration.
- Delicacy & Strict Regulations: Higher sensitivity to damage and stringent, lengthy, and expensive regulatory approval standards required to maintain product quality.
Global Non-Animal Softgel Capsule Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (Base Year) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Product Type | Starches & Pullulan (dominant material shares for plant-based casings) | Pullulan & Modified Starches (driven by superior clarity and oxygen-barrier properties) |
| By Application | Health Supplements (primary share in nutraceutical and vitamin applications) | Pharmaceuticals (expanding due to safety, purity, and stability advantages) |
| By Region | Asia-Pacific (leading regional market volume and geriatric-driven demand) | Europe (fast-growing potential backed by rising health and clean-label awareness) |
Major Industry Players Profiled
Key enterprises shaping the competitive global non-animal softgel capsule market include Procaps Laboratories, Bahrain Pharma, Aenova, SIRIO, Robinson Pharma, and Ayanda.
Download Free Sample Report
Global Non-Animal Softgel Capsule Market Size
The size of the global non-animal softgel capsule market was worth USD 15.99 billion in 2025. The global market is anticipated to grow at a CAGR of 3.8% from 2026 to 2034 and be worth USD 22.37 billion by 2034, up from USD 16.60 billion in 2026.
MARKET SCENARIO
Capsules are an available medication form that is often soft in nature and made of gelatin. Previously, this animal gelatin was used. However, today we have a non-animal version also available. This variant is believed to be more durable, viable, and stable than the animal format. They are similar in nature to the other variants available and can have different shapes, colors, and sizes. These variants are also often lacking all gluten and modified sugars, and with growing love towards body health and hate towards gluten, the market is growing exponentially. They are also thought to have more advantages associated with them, including easy-to-swallow, purity, tastelessness, odorless, safety, kosher or halal certified, clarity, texture, non-brittleness, ease of visible tampering, and others. The increasing geriatric population has prescribed these versions for more comfortable usability. They are often a part of the health industry apart from the pharmaceutical industry. The growing market for environmental products is rampantly helping the non-animal soft gel market to grow.
However, these capsules are relatively more delicate and are also prone to damage easily. The quality of these capsules gets compromised, which can be a danger to the taker. Therefore, a strict quality standard is in place, making the process of approval lengthy, demanding, and expensive.
Further, they also are more expensive than the existing animal gelatin version. It is predictable slow the growth of the global non-animal softgel capsule market substantially. Research in this field is underway, and many big and small players are joining hands to incentivize these drug formats.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Product Type, Application, and Region. |
| Various Analyses Covered | Global, Regional, and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
| Market Leaders Profiled | Procaps Laboratories, Bahrain Pharma, Aenova, SIRIO, Robinson Pharma and Ayanda |
REGIONAL ANALYSIS
Regionally, APAC is one of the major markets for these capsules because of the growing geriatric population in these regions. The Asia Pacific, as a whole, also holds a significant portion of non-animals in the world, which makes it a massive market for non-animal soft gel capsules. Many countries like Malaysia and Indonesia have a such high demand to export these variants from across other regions. There is also a significant potential market for Europe since health awareness in these regions has been on the rise.
KEY MARKET PLAYERS
Some of the notable companies leading the global non-animal softgel capsule market profiled in this report are
- Procaps Laboratories
- Bahrain Pharma
- Aenova
- SIRIO
- Robinson Pharma
- Ayanda
GLOBAL NON-ANIMAL SOFTGEL CAPSULE MARKET NEWS
- On May 30, 2019, a whole contract manufacturer of soft gel capsules, which is a nutraceutical and dietary supplement, made a public statement regarding the launch of funding programs by Robinson Pharmacy Inc., inventory support from RPI to help the clients.
- On June 04, 2015, the opening of the first phase of the nutrition facility of USD 81 billion made Amway's public statement. This facility will be added to the Nutrilite Company's manufacturing options for vitamins and minerals and dietary supplements.
- On August 27, 2019, Stride Pharma’s site underwent the U.S. FDA examinations and acquired a manufacturing facility from Micelle BioPharma.
- On March 05, 2019, GNC’ Nutra manufacturing division was integrated into IVC’s operations, which has made a public statement that it has formed a joint venture with the leading nutritional supplement named International Vitamin Corporation.
- On August 04, 2017, J+D labs were finely arranged in the nutraceutical organization, a top leading manufacturer of vitamin, mineral, and nutritional supplements. Captek Sofgel International Inc. a California-based contract manufacturer of custom dietary supplements, has made a public statement that it is acquiring J+D labs.
- On February 07, the Irish conglomerate DCC made its first healthcare with the US, and Elite Company is keeping the focus on producing nutritional products in various packaging formats.
MARKET SEGMENTATION
This research report on the global non-animal softgel capsule market has been segmented and sub-segmented into the following categories.
By Product Type
- Starches
- Pullulan
- Other
By Application
- Pharmaceutical
- Health Supplements
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa